-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Researchers at the Wilmot Institute for Cancer Research have taken another step toward understanding the complex genetic interactions that cause cell malignancy
Discrete genetic mutations that drugs can target have only been identified in a small number of cancer types
One of the lead authors of this study, Dr.
"Targeting non-mutated proteins is a broader approach that can be used for many types of cancer," Land said, "but it is difficult to find these non-mutated, essential genes
This is why Land sought collaboration with Dr.
Land’s research team had previously discovered a very diverse set of non-mutant genes that are essential for cancer
McCall said: "There are too many interactions, and you may waste a lot of time, energy and money to test interactions that may be useless
Depending on the context, the number of possible gene network models considered by TopNet is many times greater than the estimated number of atoms in the universe
Land said: "This method essentially helps us sort out a hair ball in the gene network
The research team has tested the samples of gene interaction published by TopNet, and has confirmed that this interaction is functionally related through experiments on cells and mice
Article title
Gene network modeling via TopNet reveals functional dependencies between diverse tumor-critical mediator genes
